News ArticleMax Healthcare Institute Limited Reports Ongoing Legal Proceedings at NCLT with Next Hearing on December 14, 2026
Petitions filed against subsidiary Kalinga Hospital Ltd and Max Healthcare are being considered by NCLT Cuttack Bench with a hearing adjourned to December 14, 2026
Max Healthcare Institute Limited announced developments in legal proceedings involving its subsidiary Kalinga Hospital Ltd, with hearings at the National Company Law Tribunal (NCLT) Cuttack Bench ongoing and the next hearing scheduled for December 14, 2026. The disclosure details the continuation of petitions filed by BRS Capital Two Pte. Limited's legal representatives and the tribunal's order received on November 3, 2026.
Max Healthcare Institute Limited
Legal / Regulatory
Max Healthcare Institute Limited has disclosed ongoing litigation at the National Company Law Tribunal (NCLT) Cuttack Bench involving its subsidiary Kalinga Hospital Ltd and other shareholders, with the next NCLT hearing scheduled for December 14, 2026.
The legal petitions, including interlocutory ones, were filed by the legal representatives of BRS Capital Two Pte. Limited against Kalinga Hospital Ltd, a subsidiary of Max Healthcare, as well as other shareholders and the company itself.
The matter was heard on October 30, 2026, and at the request of all involved counsels, the hearing was adjourned to December 14, 2026 for further consideration.
Max Healthcare received the NCLT's order on November 3, 2026 at 2:13 pm IST, confirming the adjournment and further proceedings.
There is no litigation against the key management personnel or promoters related to this matter, nor has any settlement been reached so far.
Highlights
- Petitions filed against Kalinga Hospital Ltd involving Max Healthcare’s subsidiary by BRS Capital Two Pte. Limited’s legal representatives.
- NCLT Cuttack Bench heard the matter on October 30, 2026.
- Next NCLT hearing scheduled for December 14, 2026.
- Order of NCLT received by Max Healthcare on November 3, 2026 at 2:13 pm IST.
- No litigation involving key management or promoters disclosed.
- No settlement or compensation details announced yet.
Key Data Snapshot
What happened
- Max Healthcare Institute disclosed ongoing legal petitions filed at NCLT Cuttack Bench related to its subsidiary Kalinga Hospital Ltd and other shareholders.
- Petitions were heard on October 30, 2026, and the case was adjourned upon request to December 14, 2026 for further proceedings.
- The company received the order from NCLT confirming the adjournment on November 3, 2026.
- The petitions originate from legal representatives of BRS Capital Two Pte. Limited.
Regulatory and governance context
- The disclosure is made under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.
- No litigation involving Max Healthcare’s key management personnel or promoters is reported in this matter.
- No settlements, penalties, compensation, or financial impact related to the proceedings have been reported to date.
Highlights
- Petitions filed against Kalinga Hospital Ltd involving Max Healthcare’s subsidiary by BRS Capital Two Pte. Limited’s legal representatives.
- NCLT Cuttack Bench heard the matter on October 30, 2026.
- Next NCLT hearing scheduled for December 14, 2026.
- Order of NCLT received by Max Healthcare on November 3, 2026 at 2:13 pm IST.
- No litigation involving key management or promoters disclosed.
- No settlement or compensation details announced yet.
Disclosures
- SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Regulation 30
More News on Legal / Regulatory
View allLatest corporate announcements and market updates in Legal / Regulatory.
Dhoot Transmission Limited Confirms Full Utilization of Rs. 1400 Crore IPO Proceeds in Q2 FY27 as Per Monitoring Agency Report
Dhoot Transmission Limited has submitted the Monitoring Agency Report from CARE Ratings Limited for the quarter ended September 30, 2026, confirming that the Rs. 1400 crore fresh issue proceeds raised through its IPO have been fully and appropriately utilized according to the offer document.
Read Full Story
Fractal Analytics Utilizes Rs. 82.1 Crore of IPO Fresh Issue Proceeds in Q2 FY27, CARE Ratings Confirms
Fractal Analytics Limited has utilized Rs. 82.1 crore from its Rs. 1,023.5 crore IPO fresh issue proceeds during the quarter ended September 30, 2026, primarily for product development, marketing, and employee equipment, with no deviations reported by CARE Ratings, the appointed Monitoring Agency.
Read Full Story
CORONA Remedies Limited Receives ₹4.88 Crore Demand Notice from NPPA Alleging Pricing Violation
CORONA Remedies Limited announced that it received a demand notice from the National Pharmaceutical Pricing Authority (NPPA) dated November 3, 2026, alleging a violation of the Drugs (Prices Control) Order, 2013, with a total demand amounting to ₹4,87,97,160 including interest and penalty.
Read Full Story
